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Abstract: Galectin-1 (GAL-1) belongs to the family of β-galactoside-binding lectins. It regulates cell-cell and cellmatrix interactions, the immune response, apoptosis, cell cycle, RNA splicing and neoplastic transformation. We
investigate the effect of heart manipulation secondary to cardiac surgery on the level of GAL-1 in murine heart
and plasma. Male C57B6/J mice were used for adopted model of cardiac surgery. Heart samples were processed
for immunohistochemical and immunofluorescent labeling, Enzyme linked immunosorbent assay and quantitative
RT-PCR to identify GAL-1 levels in the heart and plasma during the first 24 hours following cardiac surgery. There
is significant increase of GAL-1 in the LV at 30 minutes (P<0.000), 60 minutes (P<0.001), 4 hour (P<0.003), and
24 hour (P<0.003) time points of surgically operated groups compared to non-operated control group, while GAL-1
mRNA levels in any of the surgically operated groups are not significantly different from the non-operated group suggesting extracardiac origin of this raise of GAL-1. There is significant increase of GAL-1 in the plasma at 30 minutes
(P<0.000), 60 minutes (P<0.009), 4 hour (P<0.043), and 24 hour (P<0.000) time points of surgically operated
groups compared to non-operated control group. In conclusion, GAL-1 is valuable biomarker of surgical stress.
Keywords: Heart, surgical stress, galectin-1

Introduction
Galectin-1 (GAL-1) belongs to the family of
β-galactoside-binding lectins [1]. GAL-1 is a
14.5-kDa protein which forms lattice-like complexes with receptors that participate in recognition of cell-matrix [2-5]. GAL-1 regulates cellcell and cell-matrix interactions, the immune
response, apoptosis, cell cycle, RNA splicing
and neoplastic transformation [5-11]. Intracellular GAL-1 has been shown to be present
mainly in cells cytosol and less likely in nuclei
depending upon various types and conditions
of the cells [12]. GAL-1 is endogenous to the
heart but its upregulation in the myocardium
has been reported in literature following myocardial infarction [13, 14]. Surgical stress is the
body reaction to surgical manipulation and
characterized by activation of the sympathetic
nervous system, endocrine responses as well
as immunological and haematological changes
leading to disturbances of metabolic and physi-

ological processes that induce changes in the
acute phase, inflammatory, hormonal, and
genomic responses of the body [15]. Openheart surgical procedures are associated with
an inflammatory response that is largely the
result of surgical trauma [16, 17]. In this study
we investigate the effect of heart manipulation
secondary to cardiac surgery on the level of
GAL-1 in murine heart and plasma.
Material and methods
Animal groups
Male C57B6/J mice were used for the surgical
procedure for the following time points: 30 minutes, 60 minutes, 4- hour and 24- hour post
operation. Samples from non-operated animals
(Naïve) were also studied. The Animal Research
Ethics Committee of the College of Medicine
and Health Sciences, UAE University have
approved all experimental procedures; Protocol
No.A12/10.
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ed. The pericardial sac was
removed and an 8-0 silk suture
was passed in the myocardium at
Groups
N Mean (ng/mg) Std Dev Std Error P value
the anterior surface of the heart
Non-operated control 6
68.21
12.42
5.07
for one second and then removed.
30 min post surgery
6
116.75
18.76
7.66
0.000*
The chest wall then was closed
60 min post surgery
6
93.35
6.42
2.62
0.001*
by approximating the third and
4 hours post surgery 6
92.28
8.78
3.58
0.003*
fourth ribs with one or two inter24 hours post surgery 6
88.28
3.03
1.24
0.003*
rupted sutures, the muscles
*Shows P<0.05 in surgically operated vs non-operated control groups.
returned back to their original
position and the skin closed with
4-0 prolene suture. The animal was gently disconnected from the ventilator and spontaneous breathing was seen immediately. Postoperative analgesic (Butorphanol 2 mg/kg,
s/c, 6 hourly) was given at the end of the procedure. According to the experimental protocol
mice were sacrificed at desired time points.
Blood was collected in EDTA vacutainers and
the heart was resected, washed in ice cold
phosphate buffered saline (PBS), the right ventricle and both atria were dissected away and
LV was immediately frozen in liquid nitrogen
and later stored in -80°C freezer. Collected
blood was centrifuged at 3000 RPM for 15 minutes. The plasma was collected, alliquoted and
Figure 1. Graphical representation of the Galectin-1
stored at -80°C until further analysis. Heart
levels in the LV at different post operated time points.
*Shows P<0.05 in non-operated control vs surgically
samples from the same time points were also
operated groups.
fixed in 10% buffered formal-saline for 24
hours. Heart samples from the same time
points were also fixed in 10% buffered formalMurine surgical procedure
saline for 24 hours and in RNA stabilization
solution to be processed later.
C57B6/J mice (male, age: 12-16 weeks; wt:
20-25 g) were anesthetized by an intraperitoRNA isolation and quantitative reverse tranneal injection of a combination of Ketamine
scriptase PCR
(100 mg/kg) and Xylazine (10 mg/kg). The mice
were then intubated and ventilated. We adopt a
The mouse LV heart samples were homogemouse model similar to open-heart surgery to
nized in TRI Reagent (Ambion), and RNA was
fulfill the requirements for inclusion criteria of
isolated by phenol-chloroform method [21].
this project. The inclusion criteria includes
RNA pellet was resuspended in nuclease-free
opening of the chest wall, removal of pericardiwater and stored at -80°C. RNA was quantified
um, and one passing a stitch needle in the left
using a NanoDrop spectrophotometer and
ventricle (LV) and taking it out in intubated venreverse transcribed using High-Capacity cDNA
tilated anaesthetized mice to be followed by
Reverse Transcription kit (Part #4368814, PN
closure of chest and skin and scarification at
4374967; Applied Biosystems Inc, Foster City,
30 minutes, 60 minutes, 4- hour and 24- hour
CA, USA) according to the recommended protopostoperatively. The adopted surgical procecol. cDNA was diluted 1:10 and amplified by
dure is similar to the sham myocardial infarcreal-time PCR using target-specific TaqMan
tion surgery done on the mice as described
gene expression assays using the 7500 Realelsewhere [18-20].
Time PCR system (Applied Biosystems). Each
well was run in duplicate for gene of interest
Briefly, the chest was opened with a lateral inciand reference primer 18S rRNA (Applied
sion at the 4th intercostal space on the left side
Biosystems). The primers and probes for
of the sternum and the chest wall was retractTable 1. Galectin-1 levels in ng/mg of total protein at different
time points after surgical operation
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Figure 2. Galectin-1 in the heart. A. Low power view of heart from non-operated control group showing low and
patchy expression of GAL-1, mainly in the right ventricle (arrow head) and interventricular septum (thin arrow), Immunoperoxidase streptavidin-biotin method. B. High power view of left ventricle tissue from non-operated control
group showing spotty low expression of GAL-1 mainly in endothelial cells (arrow head) and cardiomyocytes sarco-
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lemmal membrane (thin arrow), Immunoperoxidase streptavidin-biotin method. C. High power view of left ventricle
tissue from non-operated control group showing spotty low expression of GAL-1 mainly in endothelial cells (arrow
head) and cardiomyocytes sarcolemmal membrane (thin arrow) giving a mesh-like pattern, Alexa Fluor 488, immunofluorescent technique. D, G, J, M. Low power views of heart from surgically operated groups at 30 min, 60
min, 4 hour, 24 hour post-operatively time points showing higher patchy expression of GAL-1in the left ventricle
and interventricular septum (thin arrow), the right ventricle is also showing expression of GAL-1 (arrow head), Immunoperoxidase streptavidin-biotin method. E, H, K, N. High power views of left ventricle from surgically operated
groups at 30 min, 60 min, 4 hour, 24 hour post-operatively time points showing higher patchy expression of GAL-1
in cardiomyocytes (thin arrow) and endothelial cells (arrow head), Immunoperoxidase streptavidin-biotin method. F,
I, L, O. High power views of left ventricle from surgically operated groups at 30 min, 60 min, 4 hour, 24 hour postoperatively time points showing higher patchy expression of GAL-1 in cardiomyocytes (thin arrow) and endothelial
cells (arrow head) of left ventricle, Alexa Fluor 488, immunofluorescent technique.

Table 2. GAL-1 mRNA fold expression in the left ventricle following
surgery
Groups

N

Non-operated control
30 min post surgery
60 min post surgery
4 hours post surgery
24 hours post surgery

6
6
6
6
6

Mean mRNA Fold
Std Dev Std Error P value
Expression
1.041
0.31
0.12
0.78
0.27
0.11
0.15
1.23
0.25
0.10
0.26
1.32
0.22
0.09
0.11
0.95
0.13
0.05
0.50

Table 3. Plasma Galectin-1 levels in ng/ml at different time points
after sham operation
Groups
Non-operated control
30 min post surgery
60 min post surgery
4 hours post surgery
24 hours post surgery

N Mean (ng/ml) Std Dev Std Error
6
8.71
2.04
0.83
8
14.52
2.21
0.74
8
13.83
3.92
1.38
6
10.64
2.51
1.02
6
17.86
2.63
0.93

*Shows P<0.05 in surgically operated vs non-operated control groups.

GAL-1 (Mm00839408_g1) and 18S rRNA
(Mm03928990_g1) were purchased from
Applied Biosystems. Data acquisition was done
by using 7500 software v2.0.6 (Applied
Biosystems). Analysis was carried out using the
comparative Ct method. The level of GAL-1
expression was normalized to 18S rRNA, and
fold changes were calculated relative to expression in sham-operated LV heart tissue using
the formula 2-ΔΔCt. Many aspects of Minimum
Information for Publication of Quantitative RealTime PCR Experiments guidelines were taken
into consideration for methods and analysis
[22].
Sample processing for protein extraction
Total protein was extracted from heart samples
by homogenizing on ice and then centrifugation
at 14000 RPM for 15 minutes at 4°C. Supernatant was collected, alliquoted and stored
7160

P value
0.000*
0.009*
0.043*
0.000*

at -80°C until further analysis. Total protein concentration
was determined by BCA protein assay method (Thermo
Scientific Pierce BCA Protein
Assay Kit).
Sample processing for histology
Each heart was sectioned,
casseted and fixed directly in
10% buffered formalin. Sections were dehydrated in increasing concentrations of ethanol, cleared with xylene and
embedded with paraffin. Three-μm sections were prepared from paraffin blocks and
stained with haematoxylin and
eosin. The stained sections
were evaluated by the histopathologist that participated in
this project.

Immunohistochemistry
Five- μm sections were cut, dewaxed and rehydrated with graded alcohol. Pre-treatment procedure to unmask the antigens was performed
in a microwave oven for 10 minutes. Sections
were incubated overnight with anti- GAL-1 (rabbit antimouse polyclonal antibody 1:2500,
Davids Biotechnologie GmbH, Germany) antibodies at 4°C. After conjugation with primary
antibodies, sections were incubated with biotin-labeled secondary antibody (Thermo
Scientific, USA) for 20 minutes at room temperature. Finally, sections were incubated with
streptavidin-peroxidase complex for 20 minutes at room temperature (Thermo Scientific,
USA), DAB chromogen (Thermo Scientific, USA)
added and counter staining done with haematoxylin. Appropriate positive and negative controls were used.
Int J Clin Exp Pathol 2015;8(6):7157-7164
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Results
Galectin-1 in response to surgical stress in the
heart

Figure 3. Graphical representation of the Galectin-1
levels in the plasma at different post operated time
points. *Shows P<0.05 in non-operated control vs
surgically operated groups.

Immunofluorescent labeling
5 µm sections were deparaffinized and rehydrated with graded alcohol. Sections were
placed in EnVision™ FLEX Target Retrieval
Solution with a high PH (PH 9) (DAKO Cytomation, Denmark) in a water bath at 80°C for
one hour. Later they were incubated with antiGAL-1 (rabbit anti-mouse polyclonal antibody
1:50, Davids Biotechnologie GmbH, Germany)
overnight at room temperature. Sections were
subsequently incubated with Donkey anti-rabbit Alexa Fluor 488, (Invitrogen, USA, 1: 50).
Finally, sections were mounted in water-soluble
mounting media and viewed with Olympus
Fluorescent microscope.
Enzyme linked immunosorbent assay
Left ventricular myocardial and plasma concentration of GAL-1 was determined using DuoSet
enzymelinkedimmunosorbentassay(ELISA)Development kit (R&D Systems, Minneapolis, MN,
USA) for sandwich ELISA, using standard procedure according to the manufacturer’s instructions.
Statistical analysis
Statistical analysis is done using IBM SPSS
Statistics version 20. Data are presented in
mean ± S.E. Statistically significant differences
(P<0.05) were calculated between each surgically operated group and the non- operated
naïve group by students t test.
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GAL-1 concentration in LV tissue of non-operated control animal group was measured to be
66.32±4.69 ng/mg. GAL-1 concentration in LV
tissue of surgically operated mice at different
time points of surgical stress are presented in
Table 1. There is significant increase of GAL-1 in
LV at all tested time points compared to nonoperated control group (Figure 1). In normal
heart, GAL-1 is mainly seen to be expressed by
cardiomyocytes and endothelial cells (Figure
2A-C). The expression is more pronounced in
the right ventricle as compared to the left ventricle (Figure 2A). In the LV, GAL-1 is mainly
expressed by endothelial cells and few cardiomyocytes (Figure 2C). A very characteristic
staining pattern is seen in immunofluorescent
labeling of GAL-1, which gives a mesh-like staining pattern of myocardium. While in the surgical
operated groups at 30 minute, 60 minute, 4
hour and 24 hour time points, we have increase
in the expression of GAL-1 by cardiomyocytes
and endothelial cells in the LV (Figure 2F-O) as
compared to the non-operated group (Figure
2A-C)
GAL-1 mRNA expression in post surgery
groups
GAL-1 mRNA levels in all surgically operated
groups are not significantly different from the
non-operated group (Table 2).
Plasma Galectin-1 in response to surgical
stress: The concentration of GAL-1 in plasma of
non-operated control animals was measured to
be 8.71 ng/ml. The level of GAL-1 in surgically
operated groups is shown in Table 3. There are
significant higher levels of GAL-1 in the surgically operated groups compared to the nonoperated controls (Figure 3).
Discussion
The major observation in this study is that
GAL-1 levels in the heart and plasma are significantly raised in response to cardiac surgeries
in mice. Our adopted murine model of cardiac
surgery includes thoracotomy, pericardiectomy
and a minor surgical injury to the LV tissue
induced by passing the stitch needle once in
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the LV. The observed increase in GAL-1 levels in
the plasma and heart tissue suggests that
GAL-1 may be part of the surgical stress
response proteins.
It is well known that surgical trauma results in
derangements of metabolic and physiological
processes that can disrupt the inflammatory,
acute phase, hormonal, and genomic responses [15]. Surgical stress response is triggered by
the nervous system that sends impulses from
the injured site to the hypothalamus. The hypothalamus either stimulates or inhibits the
release of pituitary hormones. Pituitary hormones induce the release of the stress hormone, cortisol [23]. Cortisol, glucagon, catecholamines, and some inflammatory cytokines
are the major players in the stress response to
surgery. They are responsible for tachycardia,
nervousness and hypermetabolic state, which
itself lead to increased stress on the heart.
Open heart surgery is associated with acute
perioperative changes in plasma levels of cortisol [24].
GAL-1 has been linked to stress in a research
study by Iwamoto et al. [25]. In this study GAL-1
levels in the serum were found to be significantly higher in animals subjected to stress by
restraining the animals. The pattern of change
was found to be similar to that of corticosterone. A very interesting observation made in
the same study was that the increase of GAL-1
was prevented by a neurotoxin, 6-hydroxydopamine (6-OHDA), which destroys the noradrenergic nerve terminals, suggesting that the stressinduced increase of GAL-1 is regulated by the
sympathetic nervous system.
The heart is densely innervated by sympathetic
nerve fibers [26]. The increase in GAL-1 levels
in the LV tissue of the operated group may be
due to the general effect of sympathetic stimulation of the nerve terminal of the heart in
response to surgery. This idea is further supported by the fact that we observed no changes
in LV GAL-1 mRNA levels between non-operated
control group and all the postoperative groups.
This suggests that the initial increase in GAL-1
in heart tissue and subsequently the plasma
may not be due to the GAL-1 transcribed in the
heart tissue but due to GAL-1 production by the
sympathetic nerve endings in the heart.
In surgically operated groups, we observed that
GAL-1 immunoreactivity was focally increased
7162

in the cytoplasm of cardiomyocytes in the LV. In
this case the increase in GAL-1 can be due to
the effect of injury to the myocardium sustained
during the operation. Also the effect of pericardiectomy and thoracotomy on the heart and
plasma should be taken into account. The idea
of increase GAL-1 at the site of injury is not new.
GAL-1 was found to be increased at the site of
skeletal muscle injury [27]. GAL-1 can promote
both myoblast fusion and axonal growth following muscle injury and play a role in regenerating
skeletal muscles. Immunostaining analysis of
GAL-1 in injured spinal cords also showed GAL-1
-expressing cells assembled around the lesion
site [28]. We propose therefore, that the
increase in GAL-1 levels in the heart may partly
be due to the focal injury to the cardiomyocytes
and partly due to the sympathetic stimulation
of the heart as part of the surgical stress
response.
The pattern of GAL-1 levels at different time
points following cardiac surgery is also very
important. We have seen a sharp increase in
GAL-1 levels after 30 minutes post operatively
and later remains elevated, but towards the 24
hour time point it starts going down. This pattern also points towards GAL-1 as an acute
stress player which increases in concentration
locally immediately following injury but as the
body’s homeostatic mechanism takes effect its
level starts to come down. However, we do not
see the same pattern in the plasma where we
have observed higher levels at 24 hours post
operation. A possible explanation for this phenomenon may be related to the fact that GAL-1
is expressed in activated T-Cells [29] and major
surgery is one factor that enhances the early
phase of T lymphocyte activation [30] which
may have led to this increase in plasma GAL-1
at 24 hours postoperatively.
We believe that there should be a purpose for
this rise in GAL-1 at very early time postoperatively. GAL-1 is cardio protective as it plays a
critical role in controlling acute inflammation
[31], apoptosis [32, 33] and neovascularization
[34]. Its upregulation possibly can be a part of
survival mechanism to protect the heart after
surgical insult. GAL-1 is also part of the hypoxiaregulated transcriptome [14, 35], and a component of the contractile apparatus in cardiomyocytes [36] suggesting a potential role in
modulating cardiac function. GAL-1 up regulation in the heart after surgical manipulation can
Int J Clin Exp Pathol 2015;8(6):7157-7164
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have important implications in the postoperative recovery phase [37, 38]. The therapeutic
administration or modulation of its expression
in cardiac tissue can present as a potential
novel strategy to prevent postoperative
complications.
In conclusion, GAL-1 is valuable biomarker of
surgical stress. More work is needed to clarify
further the role of GAL-1 as a stress marker for
surgical trauma particularly related to open
heart procedures. This work has opened a
small window for looking at GAL-1 from a new
perspective.
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